Conivaptan Hydrochloride and Cytarabine liposome Intrathecal

• Generic Name: conivaptan
• Dosage Forms: n.a.
• Other Brand Names: Vaprisol

Used to increase serum sodium concentrations in hospitalized patients with euvolemic or hypervolemic hyponatremia. Use in patients with hypervolemic hyponatremia associated with heart failure only after consideration of other treatment options; limited data on safety in this patient population. (See CHF under Cautions.)

Not indicated for the treatment of hypovolemic hyponatremia.

Use of conivaptan to increase serum sodium concentrations has not been established to provide symptomatic benefit to patients.

Not indicated for the treatment of CHF; efficacy not established for this indication.

• Generic Name: cytarabine liposomal
• Dosage Forms: n.a.
• Other Brand Names: DepoCyt

Liposomal cytarabine belongs to the group of medicines known as antineoplastics. It is used to treat cancer of the lymph system that has spread to the brain.

Liposomal cytarabine interferes with the growth of cancer cells, which are eventually destroyed. Since the growth of normal cells may also be affected by the medicine, other effects may also occur. Some of these may be serious and must be reported to your doctor. Some effects may occur after treatment with liposomal cytarabine has been stopped.

Before you begin treatment with liposomal cytarabine, you and your doctor should talk about the good cytarabine liposome will do as well as the risks of using it.

Liposomal cytarabine is to be administered only by or under the immediate supervision of your doctor.